Clinical Trial Update: Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a novel dentifrice for antihypersensitivity efficacy in dentin hypersensitivity is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• Novel dentifrice (investigational)

Snippet

Sponsor: HALEON | Conditions: Dentin Hypersensitivity | Phase 3 | Status: ACTIVE_NOT_RECRUITING